Deep phenotyping of sleep and symptoms in adolescents with psychosis-spectrum conditions

Active Project Grant Awarded

Award ID
R21MH142950
Recipient
Awarding agency
Obligated
$398,669

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 16% complete
Place of performance
Riverside, East Providence, RI 02915, USA

Award details come from USAspending.gov.

About this award

The National Institute of Mental Health awarded Emma Pendleton Bradley Hospital $398,669 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the relationship between sleep disruption and psychosis-spectrum symptoms in adolescents aged 14–17 years.

The research addresses three mechanistic gaps in the literature: the absence of dense sampling across days to measure temporal fluctuations between psychosis-spectrum symptoms and sleep in youth; reliance on nonspecific behavioral sleep indices rather than neurobiological markers; and omission of psychological stress measurement as a potential mediator or moderator of the sleep-psychosis relationship. The study enrolls 40 participants and measures psychosis-spectrum symptoms (hallucinations and paranoia), subjective stress ratings, and sleep characteristics across a three-week sampling period. Sleep assessment combines behavioral indices—actigraphy-estimated duration, fragmentation, efficiency, timing, rhythmicity, and regularity—with biological markers including polysomnography and EEG-indexed sleep spindle density, amplitude, and duration. Participants complete a baseline interview assessing eligibility, psychosis-spectrum symptoms, sleep, and stress prior to the intensive sampling phase.

Bradley Hospital, a non-profit pediatric psychiatric research organization based in Riverside, Rhode Island, serves as the prime recipient. The period of performance extends through June 30, 2028. Brown University serves as a sub-recipient, contributing to deep phenotyping of sleep and symptoms in adolescents with psychosis-spectrum conditions.

Description

Abstract
Adolescents experiencing psychosis-spectrum (PS) symptoms are at high risk for lifelong mental illness and impairment, including conversion to schizophrenia. Mechanisms influencing the onset or persistence of PS symptoms in adolescence are unclear. Sleep is altered in youth at clinical high risk for psychosis (CHR) compared to controls, and sleep problems may predict the transition to full-threshold psychosis and persist in first episode psychosis (FEP). Studies of sleep and PS symptoms in youth suffer from three main gaps. First, extant studies are overly correlational, with few studies using dense sampling across days to understand temporal fluctuations between PS symptoms and sleep in youth. Second, nonspecific behavioral indices of sleep (from self-report and actigraphy) may reveal the clinical presentation of sleep deficits but not the root mechanistic cause of these difficulties. Finally, studies of sleep in this population have omitted measurement of important CO-occurring processes such as stress, which may mediate or moderate the sleep-psychosis relationship in ways important for treatment development. This study seeks to address these three critical gaps by investigating daily fluctuations in PS symptoms, sleep at behavioral and neurobiological levels, and psychological stress in adolescents with PS conditions (n = 40, aged 14-17 years). Across a 3-week sampling period, this study will measure PS symptoms (hallucinations and paranoia), subjective ratings of stress, and objectively measured sleep characteristics, including behavioral (actigraphy-estimated sleep duration, fragmentation, efficiency, timing, rhythmicity, and regularity) and biological (simultaneous PSG/EEG-indexed sleep spindle density, amplitude, duration) markers. Participants will first complete a baseline interview to assess eligibility, PS symptoms, sleep, and stress. For the subsequent 21 days, adolescents will (1) wear a patch-based actigraphy monitor to assess sleep and 24H rest-activity rhythms; (2) complete twice-daily digital diaries probing sleep, stress, as well as PS symptom type (e.g., hallucinations and paranoid thoughts), severity, impairment, and timing; and (3) wear PSG and wearable EEG for 2 consecutive nights to index sleep spindles. This measurement supports 2 specific aims: 1) examine how subjective ratings of PS symptoms and stress fluctuate with respect to sleep on a daily basis, and 2) examine the feasibility of collecting at-home EEG data from adolescents with early phase psychosis and establish early links among spindles, PS symptoms, and stress. This study aligns with nimh objectives to 1) define brain mechanisms underlying complex behavior by characterizing sleep spindles in early psychosis, and 2) examine mental illness trajectories across the lifespan by exploring these mechanisms in an understudied adolescent population. If successful, this will be the first study to employ deep phenotyping of sleep in adolescents with early phase psychosis.

Subawards

Subrecipient Amount Awarded
Brown University Deep phenotypingofsleepandsymptomsinadolescentswithpsychosis-spectrumconditions $113,793

Quick answers

Who received award R21MH142950?

R21MH142950 was awarded to Emma Pendleton Bradley Hospital by National Institute of Mental Health (National Institutes of Health) on July 1, 2026.

How much is award R21MH142950 worth?

$398,669 has been obligated on R21MH142950.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award